The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1,1,1-Trifluoro-dec-3-yn-2-one ID: ALA356917
Chembl Id: CHEMBL356917
Cas Number: 85336-10-3
PubChem CID: 158754
Max Phase: Preclinical
Molecular Formula: C10H13F3O
Molecular Weight: 206.21
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CCCCCCC#CC(=O)C(F)(F)F
Standard InChI: InChI=1S/C10H13F3O/c1-2-3-4-5-6-7-8-9(14)10(11,12)13/h2-6H2,1H3
Standard InChI Key: LECHALRQDMTAQM-UHFFFAOYSA-N
Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 206.21Molecular Weight (Monoisotopic): 206.0918AlogP: 3.09#Rotatable Bonds: 4Polar Surface Area: 17.07Molecular Species: ┄HBA: 1HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 1HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 4.70CX LogD: 4.70Aromatic Rings: ┄Heavy Atoms: 14QED Weighted: 0.39Np Likeness Score: 0.38
References 1. Wheelock CE, Colvin ME, Uemura I, Olmstead MM, Sanborn JR, Nakagawa Y, Jones AD, Hammock BD.. (2002) Use of ab initio calculations to predict the biological potency of carboxylesterase inhibitors., 45 (25): [PMID:12459025 ] [10.1021/jm020072w ] 2. Wheelock CE, Nakagawa Y, Akamatsu M, Hammock BD.. (2003) Use of classical and 3-D QSAR to examine the hydration state of juvenile hormone esterase inhibitors., 11 (23): [PMID:14604674 ] [10.1016/j.bmc.2003.08.023 ]